Qiagen, NL0015002SN0

Qiagen stock trades at EUR 45.01 as Qiagen agrees to EUR 46.50 offer

Published on 10/25/2026 at 17:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Qiagen stock trades at EUR 45.01 in weekend trading on October 25, 2026. EQT offers EUR 46.50 per share with closing expected in mid-2027.

Offer and market timing

  • On October 21, 2026, QIAGEN agreed to support a EUR 46.50-per-share cash offer.
  • Qiagen stock trades in weekend trading at Lang & Schwarz at EUR 45.01 at 5:30 p.m. CEST on October 25, 2026.
  • The next Xetra session is scheduled for October 26, 2026.
Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

On October 21, 2026, QIAGEN N.V. agreed with EQT Private Equity on a recommended voluntary all-cash public takeover offer at EUR 46.50 per share, according to EQS News. Qiagen stock was at EUR 45.01 in weekend trading at Lang & Schwarz at 5:30 p.m. CEST on October 25, 2026.

The week in figures

The October 25 weekend indication at Lang & Schwarz was EUR 45.01. The quote is separate from the company announcement and does not establish a cause for the price level.

The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Qiagen stock.

Chronology of the week

On October 21, 2026, QIAGEN and EQT Private Equity announced the agreement on the recommended cash offer. Qiagen's Supervisory Board and Managing Board supported the transaction and agreed to recommend acceptance. The offer is subject to, among other conditions, a minimum acceptance threshold of 50 percent plus one QIAGEN share and regulatory clearances. The announcement said completion is expected in mid-2027.

Dates of the coming week

The next Xetra session is scheduled for October 26, 2026. The takeover offer has not yet begun; the offer document is to be published after approval by BaFin, according to the EQS News announcement.

Market context: Market report AEX.

Disclaimer...
en | NL0015002SN0 | QIAGEN | boerse | 70410248 | bgmi